The firm has accelerated realisations over the second half of last year, allowing it to lift its NAV per share by 4.2% since end September.
2 min read · 20 September 2013
The UK firm has bought Italian pharmaceutical group Doc Generici, its second acquisition in less than a month.
2 min read · 20 September 2013
The London-listed firm has narrowed its NAV discount by 42% in the 12 months to end February amid signs of recovery for the listed private equity sector.
2 min read · 20 September 2013
The US firm’s acquisition of Kaporal, a French fashion retailer known for its denim, comes hot on the heels of its $835m investment in US apparel maker True Religion.
1 min read · 20 September 2013
The French firm’s latest fundraising effort, which comes after abandoning plans for a top-up fund, could be facilitated by a couple of sizeable exits in the coming months.
3 min read · 20 September 2013
The addition of the €1bn Swiss fund of funds to the French bank’s private equity unit will boost its asset under management to €5bn.
2 min read · 20 September 2013
The firm’s equity injection in Nabil Foods, the sixth investment from its $500m MENA fund, will seek to tap growing demand for food imports in the region.
2 min read · 20 September 2013
The London-based firm’s second vehicle, which is more than twice the size of its maiden fund, will have a particular focus on mining and energy opportunities in Latin America.
2 min read · 20 September 2013
The Calgary-based firm, which focuses on upstream exploration and production opportunities in Canada, has sought to diversify its investor base by raising a vehicle nearly twice the size of its predecessor.
2 min read · 20 September 2013
The buyout arm of Lloyds Banking Group has divested its interest in Europe’s largest temporary access equipment maker in a deal valuing the business at more than £28 million.
2 min read · 20 September 2013